Cygnus Technologies will be presenting and exhibiting at the #CHIBioprocessingSummit next week in Barcelona! Jared Isaac, PhD MBA will present "Analytics for Process-related Impurities in Viral Vector Manufacturing" at 12:15 PM on March 18. Be sure to stop by 𝐁𝐨𝐨𝐭𝐡 49 to speak with our team and learn about new Host Cell Detection tools! #HostCellProtein #Bioprocessing #Biopharma
Cygnus Technologies, LLC
生物技术研究
Leland,NC 2,657 位关注者
The experts in biopharmaceutical impurity analysis
关于我们
Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well. Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes. Cygnus is an industry pioneer responsible for developing and commercializing the first generic assay kits for HCP detection. Its reputation for quality is recognized by the industry and global regulatory agencies. It continues to advance the science of bioprocess impurity detection with new breakthroughs, including its Antibody Affinity Extraction™ (AAE) technology and orthogonal methods of HCP analysis that integrate Mass Spectrometry, AAE and ELISA. To reduce the cost and risk associated with viral clearance studies, Cygnus also offers a unique approach that utilizes non-infectious mock virus particles through its MockV™ virus clearance kits. Cygnus’ proprietary technology, available through its off-the-shelf and custom analytics programs, sets the gold standard for enabling HCP and other bioprocess impurity antibody assays. Cygnus delivers best-in-class customer service and technical expertise, operational excellence and ISO-9001:2015 certified quality management systems. Founded by Ken Hoffman in 1997, Cygnus continues to support and advance technology in order to improve biotherapeutic safety and accelerate the movement of new therapeutics through the development and regulatory approval process. Located in Southport, North Carolina, Cygnus Technologies is online at www.cygnustechnologies.com.
- 网站
-
https://www.cygnustechnologies.com/
Cygnus Technologies, LLC的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Leland,NC
- 类型
- 私人持股
- 创立
- 1997
- 领域
- Host Cell Protein ELISA Kits、Host Cell DNA Detection & Extraction Kits、Process-Specific HCP Assay Development、Antibody Affinity Extraction、Viral Clearance和Mass Spectrometry
地点
-
主要
1523 Olde Waterford Way
US,NC,Leland,28451
Cygnus Technologies, LLC员工
-
Christopher Prophett
Managing Partner at Cygnus Technologies, LLC
-
Christine Dolan
EVP & GM at Maravai LifeSciences
-
Alla Zilberman
Vice President, Technical Marketing & Business Development at Cygnus Technologies, LLC
-
Marshall Parker
Accomplished strategic leader and QA professional leading R&D, regulatory and manufacturing in the development and commercialization of Class III/PMA…
动态
-
Need a sensitive and cost-effective assay for host cell DNA analysis? Try our new AccuRes™ kits at 20% off list price! Our CHO and 𝘌. 𝘤𝘰𝘭𝘪 AccuRes™ Host Cell DNA kits are compliant with probe-based DNA quantification methods recommended by USP General Chapter <509> “Residual DNA Testing”. Designed to be paired with your extraction method of choice, our AccuRes™ kits offer the flexibility to accommodate your qPCR workflow, sample throughput, and existing equipment. Choose your kit today and enter 𝐀𝐜𝐜𝐮𝐑𝐞𝐬𝐐120 at checkout: https://lnkd.in/eQeRHtmY #hostcelldna #bioprocessing #drugmanufacturing
-
-
Thanks to all who attended Eric's presentation and stopped by our booth at WCBP! The Cygnus team enjoyed chatting with you about residual host cell impurity detection and viral clearance prediction. See you at the next event! #WCBP2025 #HostCellProteins #Biopharma #CMC
-
-
We are excited to introduce two NEW AccuRes™ kits compliant with probe-based DNA quantification methods recommended by USP General Chapter <509> “Residual DNA Testing”! Designed to be paired with your extraction method of choice, these kits offer flexibility to accommodate your workflow and sample throughput, whether that is Cygnus' D100T or D100W kit or a similar alternative. Now available for quantifying 𝘌. 𝘤𝘰𝘭𝘪 or CHO DNA, these qPCR kits are a highly sensitive yet economical choice for your analytical needs. Try our kits today: https://lnkd.in/eXvkJsvK
-
🏆Our gold standard CHO HCP ELISA Kit, 3G (F550-1) provides the specificity and sensitivity to detect host cell protein impurities with reproducibility that supports regulatory compliance. Check out our recent article in BioProcess International on advanced characterization of our anti-CHO HCP antibody using LC-MS: https://lnkd.in/e9_xt3xi #hostcellprotein #bioprocessing #drugmanufacturing
-
🚀Cygnus is ready to kick off our 2025 event calendar at the prestigious WCBP Symposium hosted by CASSS – Sharing Science Solutions on January 28-30 in Washington, DC! 🗓️Eric Bishop, VP of R&D at Cygnus, will be presenting "Best Practices in Host Cell Impurity Analytics – Using Advanced Technologies and Methods to Monitor and Control Host Cell Proteins and Host Cell DNA" on Wednesday, January 29th at 12:25 PM EST. View the full agenda: https://lnkd.in/e3fe9cwr 🤝Our team will be exhibiting at 𝐁𝐨𝐨𝐭𝐡 5, so please make sure to stop by and speak with our technical experts about the latest impurity detection tools and services! #WCBP2025 #Biopharma #CMC
-
🚀Our CHO AccuRes™ Host Cell DNA Quantification Kits are now available in a deep-well extraction format! 🧬This all-in-one kit takes you from sample extraction to PCR, using our proprietary extraction reagents and a state-of-the-art probe-based master mix designed to deliver highly sensitive results no matter your sample throughput. Kit highlights include: 📊Accuracy—probe-based quantification ensures specificity to CHO DNA 🌡️Better precision—CleanAmp® dNTPs and Hot Start Taq DNA Polymerase reduce non-specific priming 🔀Flexibility—compatible with any qPCR instrument that detects FAM signal, eliminating the cost of purchasing additional equipment or reagents 📈Demonstrated sensitivity with an LOD of 0.6 fg/µL 💰Economical alternative to an established Quantitative CHO DNA Kit Ensure your purification process reduces DNA below regulatory limits. Save 30% on your AccuRes order with code AccuRes2430: https://lnkd.in/ed27T22a #hostcellDNA #bioprocessing #impuritydetection
-
-
Join us on Tuesday for a 30 minute #BPIAsktheExpert webcast hosted by BioProcess International! Jared Isaac, PhD MBA will present an overview of AAE/immunoaffinity chromatography and its utility in performing antibody coverage analysis for regulatory submissions. Register now: https://lnkd.in/eqwuhfZF #Hostcellprotein #Bioprocessing #Assayqualification
-
Thanks for connecting with us at FOB Basel! We kicked off this year's meeting with a packed seminar session focused on integrating advanced technologies to detect and control HCPs, followed by numerous informative discussions during the cocktail/exhibit hours. As we close out this year's event season, tell us: is there an upcoming event you're looking forward to in 2025? Let us know in the comments! #HostCellImpurities #Bioprocessing #biopharma #FestivalOfBiologics #Bioanalytics #PharmaInnovation #DrugDevelopment
-
🤝We're excited to present and exhibit at the Festival of Biologics, taking place from 15-17 October in Basel! 📢Alla Zilberman will be speaking on Day 1 to discuss the integration of advanced technologies to support and derisk your HCP ELISA analysis. 📍Our staff will be onsite at 𝗯𝗼𝗼𝘁𝗵 𝟮𝟰𝟰 to meet you. Stop by to hear about our latest solutions to support your work! #HostCellImpurities #Bioprocessing #biopharma #FestivalOfBiologics #Bioanalytics #PharmaInnovation #DrugDevelopment
-